- Home
- ITT vs ICLR Comparison
ITT vs ICLR Comparison
Compare ITT & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ITT
- ICLR
- Stock Information
- Founded
- ITT 1920
- ICLR 1990
- Country
- ITT United States
- ICLR Ireland
- Employees
- ITT N/A
- ICLR N/A
- Industry
- ITT Fluid Controls
- ICLR Biotechnology: Commercial Physical & Biological Resarch
- Sector
- ITT Industrials
- ICLR Health Care
- Exchange
- ITT Nasdaq
- ICLR Nasdaq
- Market Cap
- ITT 13.1B
- ICLR 13.7B
- IPO Year
- ITT N/A
- ICLR 1998
- Fundamental
- Price
- ITT $170.81
- ICLR $174.88
- Analyst Decision
- ITT Strong Buy
- ICLR Buy
- Analyst Count
- ITT 10
- ICLR 14
- Target Price
- ITT $182.78
- ICLR $212.62
- AVG Volume (30 Days)
- ITT 287.4K
- ICLR 984.3K
- Earning Date
- ITT 10-28-2025
- ICLR 10-22-2025
- Dividend Yield
- ITT 0.82%
- ICLR N/A
- EPS Growth
- ITT 21.12
- ICLR 13.11
- EPS
- ITT 6.36
- ICLR 9.73
- Revenue
- ITT $3,699,600,000.00
- ICLR $8,089,820,000.00
- Revenue This Year
- ITT $7.09
- ICLR N/A
- Revenue Next Year
- ITT $5.17
- ICLR $1.73
- P/E Ratio
- ITT $26.87
- ICLR $17.96
- Revenue Growth
- ITT 6.69
- ICLR N/A
- 52 Week Low
- ITT $105.64
- ICLR $125.10
- 52 Week High
- ITT $174.73
- ICLR $313.51
- Technical
- Relative Strength Index (RSI)
- ITT 56.75
- ICLR 53.80
- Support Level
- ITT $167.22
- ICLR $161.01
- Resistance Level
- ITT $174.73
- ICLR $182.67
- Average True Range (ATR)
- ITT 2.92
- ICLR 5.39
- MACD
- ITT -0.22
- ICLR -0.54
- Stochastic Oscillator
- ITT 63.42
- ICLR 64.04
About ITT ITT Inc.
ITT began its journey as International Telephone & Telegraph in 1920. Through decades of acquisitions in the mid-1900s, ITT went from manufacturing telephone switching equipment to operating hotels, car rentals, insurance agencies, and bread bakeries. In 1995, the firm split into three separate entities, one of which is the ITT in current operation. After a few more spinoffs in 2011, today ITT Inc. sells automotive, industrial, and aerospace products such as brake pads, seals, pumps, valves, connectors, and regulators. It has operations around the globe with notable exposures to North America, Europe, and Asia.
About ICLR ICON plc
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.